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Proximal deletions of the long arm of chromosome 13 have been
reported only rarely. Here we present three unrelated patients
with heterozygous, apparently de novo deletions encompassing
13q12.3. The patients present with moderate demonstrated or
apparent intellectual disability, postnatal microcephaly, and ec-
zema/atopic dermatitis as the predominant symptoms. In addi-
tion, they had pronounced feeding difficulties in early infancy.
They displayed similar facial features such as malar flattening, a
prominent nose with underdeveloped alae nasi, a smooth phil-
trum, and a thin vermillion of the upper lip. The proximal and
distal breakpoints were clustered and the deletions spanned from
1.4 to 1.7Mb, comprising at least 11 RefSeq genes. However,
heterozygous deletions partially overlapping those observed in
the present patients have been described in healthy parents of
patients with Peters-Plus syndrome, an autosomal recessive dis-
order caused by inactivation of the B3GALTL gene. We therefore
propose that the critical region of the 13q12.3 microdeletion
syndrome contains only three genes, namely, KATNAL1,
HMGB1, and LINC00426, a non-protein coding RNA. The KAT-
NAL1proteinbelongs toa familyofmicrotubuleseveringenzymes
that have been implicated in CNS plasticity in experimental
models, but little is known about its function in humans. The
HMGB1 protein is an evolutionarily conserved chromatin-asso-
ciated protein involved inmany biologically important processes.
In summary, we propose that microdeletion 13q12.3 represents a
novel clinically recognizable condition and that the microtubule
severing gene KATNAL1 and the chromatin-associated gene
HMGB1 are candidate genes for intellectual disability inherited
in an autosomal dominant pattern.  2014 Wiley Periodicals, Inc.
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INTRODUCTION
Over the past years it has become apparent that chromosomal
rearrangements below the detection level of conventional karyo-
typing are a common cause of intellectual disability (ID), account-
ing for up to 15% of unselected patients with ID [Miller et al., 2010;
Vissers et al., 2010]. However, the interpretation with regard to the
clinical significance of non-recurrent variants can be challenging
and the scientific insight gained from individual patients is often
limited. The collection of clinical and genetic information in
databases such as DECIPHER allows the identification of unrelated
patients with overlappingmicrodeletions/-duplications, thus help-
ing to establish causality, determine genotype/phenotype correla-
tion and enable the identification of novel disease-causative genes.
Using a joint collaborative effort through theDECIPHER database,
we present three unrelated patients carrying overlapping submi-
croscopic deletions at chromosome band 13q12.1–3.
Chromosome 13 has one of the lowest gene densities among
human chromosomes and interstitial deletions of 13q have only
rarely been reported by standard karyotyping or microarray analy-
sis [Drummond-Borg et al., 2002; Ballarati et al., 2007; Der
Kaloustian et al., 2011; Cirillo et al., 2012].
Here, we present three patients with overlapping heterozygous
deletions at 13q12.1–3with a recognizable phenotype characterized
by demonstrated or apparent ID, postnatal microcephaly, and
eczema/atopic dermatitis as the predominant symptoms. In addi-
tion, all three patients displayed characteristic facial features. This
phenotype is associated with a 300 kb critical region harboring
only three genes, namely KATNAL1, HMG, and the non-protein
coding RNA LINC00426.
CLINICAL REPORTS
Patient 1, a boy, was born at 42 weeks of gestation after an
uneventful pregnancy by cesarean to healthy parents of Caucasian
origin. Birth weight was 3,200 g (10–25th centile) and length 48 cm
(3rd–10th centile). The OFC was not recorded at birth but was
42 cm (10th centile) at the age of 6 months. He experienced
frequent screaming spells in the first months and severe feeding
difficulties with recurrent vomiting until the age of 21/2 years. He
needed surgery for right-sided undescended testis and bilateral hip
dysplasia. A lingual frenulum was cut at the age of 3 years. Motor
milestoneswerewithinnormal limits (sitting at the age of 6months,
walking at 15months) but language development was delayed (first
words at the age of 31/2 years). Assessment of cognitive abilities at the
age of 7 years showed an IQof 53with subtest values between 50 and
60. He displayed behavioral problems with hyperactivity and hair
pulling. An eye examination showed hypermetropia. He developed
atopic dermatitis, multiple food allergies, and allergic rhinitis. On
examination at the age of 18 years height was 165.5 cm (3rd–10th
centile), weight 66 kg (25th–50th centile), and OFC 53 cm
(2.5 SD). He had eczema on the hands, elbows, and knees and
several cafe´ au lait spots on the torso. Hands were small and feet
short. Truncal obesity and small testes were noted. The facial
features are depicted in Figures 1A,D and 2A. Note the short
palpebral fissures, fullness of upper eyelids, malar flattening, prom-
inent nosewith low insertion of the columella, underdeveloped alae
nasi, and thin vermillion of the upper lip.
Patient 2, the girl was delivered by cesarean at gestational age
37 weeks due to intrauterine growth retardation. Birth weight was
2,100 g (3rd–10th centile), length 47 cm (25th centile), and OFC
32 cm (25th centile). Her APGAR scores were 9/1, 10/5. Redun-
dant nuchal skin, a wide mouth, and a pointed chin were noted at
birth. During infancy feeding difficulties and failure to thrive were
prominent as well as recurrent vomiting, recurrent upper airway
infections and asthmatic bronchitis. At age 18 months she was
diagnosed with a diaphragmatic hernia that was surgically cor-
rected. Nevertheless, failure to thrive (height 3 SD and weight
3 SD)andrecurrent vomitingcontinued. Fromaroundage3years
her growth parameters gradually increased to normal except for the
OFC. Measurements at the age of 12 years were height 149 cm
(25th–50th centile), weight 39 kg (25th–50th centile), and OFC
49 cm (2.5 SD).
Grossmotormilestones were within normal limits (sitting at age
6 months, walking at age 14 months), but speech development was
delayed (20 words at age 3 years). She had general hypotonia,
decreased balance and stability, and severe constipation, but exten-
sive gastroenterological examinations have been normal. She also
suffered from severe atopic dermatitis but no allergies have been
documented. Furthermore, at age 31/2 years, thoracic kyphoscoliosis
and bilateral hypermetropia (þ8) became evident. Hearing was
normal. Her facial features are shown in Figures 1B,E and 2B. Note
fullness of the upper eyelids, malar flattening, a broad nasal tip,
underdeveloped alae nasi, a smooth philtrum, a thin vermillion of
the upper lip, dental crowding, and a pointed chin.
A cerebralMRIwas performed at the age 9 years due to headache
and vomiting with normal result. She was attending a school for
special needs and was able to read simple texts. The IQ was 54
assessed at the age of 9 years.
Patient 3, a girl, was delivered by forceps-assisted vaginal deliv-
ery at gestational age 36weeks. Shewas small for gestational agewith
a birth weight of 1,940 g (<3rd centile), length 38 cm (<3rd
centile), and OFC 32 cm (25th–50th centile). Her APGAR scores
were 6/1, 7/5, and 8/10. The umbilical cord was noted to be short.
She suffered from episodes of apnea that continued after the
newborn period, and displayed feeding difficulties with recurrent
vomiting. Gastro-esophageal reflux was treated until 2 years of age.
At 12.5 years (last examination) she still had feeding difficulties,
received supplemental nutrition, and suffered from chronic con-
stipation. She had short stature and was slender (height 130 cm,
corresponding to3 SD, weight 22 kg, corresponding to2.8 SD)
but showed disproportionately increased abdominal circumfer-
ence. She had normal OFC at birth, but developed postnatal
microcephaly. Her OFC at 12.5 years was 49.5 cm (2.5 SD).
She walked at 17 months of age. Her speech was delayed, and
she first started to speak in sentences at 5 years.No formal IQ testing
was performed but evaluation at the age of 12.5 years showed
apparent moderate intellectual disability with an estimated IQ
between 40 and 50. A cerebral MRI scan at the age of 3 years
was normal. She had chronic secretory otitis media since 2–3
months of age, and underwent 30 tube-operations in total. Anes-
thesia induced severe postoperative respiratory distress. She had
obstructive sleep apnea requiring continuous positive airway pres-
sure therapy at night. Plastic surgery for nasal septum deviation
reduced the apnea episodes. She had persistent hearing loss of the
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left ear and hearing impairment on the right ear, and used hearing
devices. She had hypermetropia (þ6) and strabismus. Her distinct
facial features included malar flattening, fullness of the upper
eyelids with ptosis, narrow forehead, a broad and slightly deviated
nasal tip, and underdeveloped alae nasi (Fig. 1C,F). Other features
included micrognathia, crowded teeth, oligodontia, enamel ero-
sions, and a high palate.
She had hypotonia, and the large joints were hyper extensible,
while other joints were stiff and enlarged. She had low muscle
endurance and reducedbalance. She showed camptodactyly, prom-
inent digit pads, broad fingertips, pes planus, and long great toes.
Her right leg was longer than the left. Her progressive bilateral
metatarsus adductus made it painful for her to walk, and she
underwent orthopedic surgery on both feet at 13 years of age.
She had hirsuitism on her back and lower extremities, but her hair
and nails were growing slowly and her brittle nails never needed to
be trimmed. She had eczema/atopic dermatitis but was not suffer-
ing from allergies. She had behavioral problems with hyperactivity
and self-mutilation (hair pulling and finger-biting) and temper
tantrums. She was said to have good long-term memory, but
reduced short-term memory. She was attracted by water and had
increased sensitivity to bright lights and sudden sounds. She had
tactile aversion as a newborn, and had a strikingly reduced sensi-
tivity to pain.
MATERIALS AND METHODS
The three patients were all referred to their respective centers in
Switzerland, Norway, andDenmark for evaluation of developmen-
tal delay. Blood samples were taken from the patients and their
parents after informed consent had been obtained.
Conventional Karyotyping and Microarray
Analysis
Karyotyping of G-banded metaphase chromosomes was per-
formed on cultured lymphocytes using standard procedures.
Microarray analysis was conducted using different platforms.
FIG. 1. Facial features of patient 1 (A, D) at the age 18 years, patient 2 (B, E) at the age of 31/2 years, and patient 3 (C, F) at the age of
9 years. Note similar facial features with fullness of upper eyelids, malar flattening, low insertion of the columella, underdeveloped alae nasi,
and a thin vermillion of the upper lip.
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Patient 1 was analyzed using the Affymetrix Cytogenetics 2.7M
array (Affymetrix, Santa Clara, CA). This platform provides
whole genome coverage with 400,000 SNPs and 2.3M copy
number markers. Patient 2 was analyzed with the Agilent CGH
244K array (Agilent Technologies, Inc., Santa Clara, CA), and
patient 3 with the Agilent CGH 105K array. The different arrays
were performed according to the respective manufacturer’s
instructions. The genomic positions of the deletionsweremapped
to the GRCh37/19 built, assembly Feb 2009. The deletions were
confirmed using different methods (see Results section). Analysis
of parental samples was performed but biologic parentage was
not tested.
RESULTS
Conventional chromosome analysis did not show structural rear-
rangements in any of the patients. In all patients an interstitial
heterozygous deletion involving chromosomal band 13q12 was
identified by microarray analysis (Fig. 3). Patient 1 had an appar-
ently de novo deletion of about 1.58Mb on 13q12.3 not detectable
in the parents and a second deletion of 2.5Mb on 8p22 inherited
from the healthy father (arr[hg19] 8p22 (16,513,831–19,023,017)
x1pat, 13q12.3(30,880,255–32,462,466)x1). The 13q12 deletion
was confirmed using FISH probes RP11-550P23 and RP11-
367C11. Analysis of patient 2 showed an apparently de novo
deletion of 1.4Mb (arr[hg19] 13q12.3(30,760,696x2,30,768,420–
32,166,016x1,32,192,734 2)) not present in the parental samples
whichwas confirmed by qPCR.Patient 3had an apparently de novo
deletion of 1.73Mb on 13q12.3 (arr[hg19] 13q12.3 (30,781,984x2,
30,805,425–32,533,892x1, 32,582,281x2)) not detected in the
parents.
DISCUSSION
Intellectual disability comprises a group of genetically and pheno-
typically heterogeneous entities and represents a major diagnostic
challenge in clinical genetics. Here we present three unrelated
patients with demonstrated or apparent ID with heterozygous
deletions encompassing 13q12.3 who have been identified through
the DECPHER database. Apart frommoderate ID they manifested
postnatal microcephaly, eczema/atopic dermatitis, and dysmor-
phic features. In addition, they had pronounced feeding difficulties
in infancy. While motor development was more or less within
normal limits, speech acquisition was delayed in all three patients
and they displayed behavioral problems such as hyperactivity, self-
mutilation, and reduced sensitivity to pain. Other features were
hypermetropia 3/3, oligodontia 2/3, recurrent upper airway respi-
ratory infections 2/3, and truncal obesity 2/3. Some features,
including diaphragmatic hernia, kyphoscoliosis, unequal leg
length, sleep apnea, and multiple food allergies, were observed in
one individual only. The three patients shared strikingly similar
facial features such as malar flattening, a prominent nose with
underdeveloped alae nasi, and a thin vermillion of the upper lip
(Table I and Figs. 1 and 2).
The breakpoints were clustered and the deletions spanned from
1.4 to 1.73Mb, comprising at least 11 RefSeq genes (Fig. 3). Due to
the use of differentmicroarray platforms it cannot be determined if
the proximal breakpoint was the same in all three patients. Het-
FIG. 2. Patient 1 (A) at the age 20 years and patient 2 (B) at the age of 13 years. Note malar flattening, low insertion of the columella,
underdeveloped alae nasi, and similar facial expression.
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erozygous deletions partially overlapping those observed in the
patients reported here have been described in healthy parents of
patients with Peters-Plus syndrome, an autosomal recessive disor-
der caused by inactivation of the B3GALTL gene [Lesnik Oberstein
et al., 2006; Haldeman-Englert et al., 2009]. We therefore propose
that the critical region of the 13q12.3 microdeletion syndrome
contains only three genes, namely, KATNAL1, HMGB1, and
LINC00426.
The LINC00426 (long intergenic non-protein coding RNA 426)
transcript is a non-coding RNA of unknown function. Whether
haploinsufficiency of this gene causes or contributes to the pheno-
type remains open.
The second gene in the critical region is KATNAL1 (KATANIN
p60 subunitA-like 1), which codes for a recently identified ATPase
with high sequence similarity to KATANIN p60 (KATNA1), a
member of themicrotubule-severing enzyme family. Microtubules
are dynamic cytoskeletal polymers that play important roles in cell
division, morphogenesis, mobility, and signaling. The remodeling
of microtubules is mediated by microtubule-severing enzymes
[Sharp and Ross, 2012]. The KATANIN protein exists as a hetero-
dimer of a 60-kDa catalytic subunit (p60, KATNA1) and a 80-kDa
targeting and regulatory subunit (p80, KATNB1) [McNally and
Vale, 1993]. Katanin andKatanin-like proteins are highly expressed
in the nervous system of diverse organisms [deMoor et al., 2012]. A
neuronal function forkataninwasfirstdemonstrated in cultured rat
neurons where it was shown to stimulate axonal outgrowth and
establish neuronal polarity [Ahmad et al., 1999; Yu et al., 2005].
Knowledge of the role of the katanin like proteins is still limited.
Recently, however, de novo mutations in KATNAL2 (KATANIN
p60 subunit A-like 2), a close family member of KATNAL1 (the
gene deleted in the patients reported here) have been identified in
patients with autism spectrum disorders by exome sequencing
[Neale et al., 2012; Sanders et al., 2012].
The third gene located in the critical deletion interval isHMGB1
(High-Mobility Group Box 1) which belongs to the HMG-box
family. TheHMGBproteins are nuclear proteins, comprised of two
DNA-binding domains (HMG boxes A and B) and an acidic tail,
which seems to have a regulatory function in DNA-binding. The
HMGB1 protein is widely expressed in all tissues of vertebrates and
is the most abundant non-histone protein in the nucleus [Bianchi
and Beltrame, 1998]. It is engaged in numerous nuclear processes
such as transcription, replication, recombination, and repair. The
importance of HMGB1 is reflected by the fact that homozygous
knock out mice die shortly after birth, very likely due to inefficient
activation of glucocorticoid receptor responsive genes [Calogero
et al., 1999]. Apart from its role as a nuclear chromatin-associated
protein, HMGB1 is released in the extracellular environment
inducing secretion of proinflammatory cytokines [Lotze and
FIG. 3. Map of the 13q12.3 locus. The deletions of the three patients reported here (continuous lines) are compared to those of healthy
heterozygotes (dashed lines) reported in the literature [Lesnik Oberstein et al., 2006; Haldeman-Englert et al., 2009] and healthy individuals
from the DECIPHER database [#1604/#1605/#1606]. The critical region, indicated by the dashed square, is about 300 kb in size and contains
the genes KATNAL1, LINC0042, and HMGB1. Array data were uploaded into the UCSC Genome Browser, GRCh37/19 build, assembly Feb 2009
[http://www.genome.ucsc.edu].
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Tracey, 2005]. Accordingly, it plays an important role in various
conditions, such as sepsis, rheumatoid arthritis, hemorrhagic
shock, ischemia-reperfusion injury, and invasive tumor growth.
With regard to the central nervous system, HMGB1 (which is
identical to the neurite outgrowth-promoting protein p30, ampho-
terin and SBP-1) displays a complex temporal and spatial expres-
sion pattern during early brain development. It promotes neurite
outgrowth andcellmigration in rat brain and is critical for forebrain
development [reviewed in Fang et al., 2012]. In adulthood, its
expression is down regulated in the majority of neurons.
For the patients reported here, haploinsufficiency of all three
RefSeq genes present in the critical regionmight potentially causeor
contribute to the ID. The HMGB1 gene is a likely candidate, since
the control of gene transcription through epigenetic modification
of the chromatin structure in neurons has been shown to play an
important role in cognitive processes and in the etiology of ID [van
Bokhoven, 2011]. Other examples of ID genes acting in the epige-
netic control of gene transcription are the genes for Kleefstra
syndrome (EHMT1) and Rubinstein–Taybi syndrome (CREBBP
and EP300). Furthermore, HMGB1 and closely related family
members of KATNAL1 have been implicated in regulation of
neurite outgrowth, which is consistent with the observation that
many ID-genes are involved in synaptic plasticity. The role of
KATNAL1 in causing ID is also supported by the recent observation
TABLE I. Comparison of Clinical Features
Patient 1 Patient 2 Patient 3
Size of deletion 1.58Mb 1.4 Mb 1.73 Mb
Platform Affymetrix 2.7 Cytoscan Agilent 244 k Agilent 105 k
Gender, age at report (years) male, 19 female, 12 female, 12.5
Height (cm) 165.5 (3rd–10th centile) 149 (25th–50th centile) 130 (3 SD)
Weight (kg) 66 (25th-50th centile) 39 (25th-50th centile) 22 (2.8 SD)
OFC (cm) 53 (2.5 SD) 49.5 (2.5 SD) 49.5 (2.5 SD)
Pregnancy, IUGR þ þ þ
Gestational age (weeks)/mode
of delivery
42, cesarean 37, cesarean 36, forceps
Birth weight (g) 3,200 (10th–25th centile) 2,100 (3rd–10th centile) 1,940 (<3rd centile)
Birth length (cm) 48 (3rd–10th centile) 47 (25th centile) 38 (<3rd centile)
OFC at birth (cm) nr 32 (25th centile) 32 (25th–50th centile)
Recurrent vomiting þ þ þ
Failure to thrive þ þ þ
Constipation þ þ þ
Fullness of upper eyelids þ þ þ
Malar flattening þ þ þ
Underdeveloped alae nasi þ þ þ
Low insertion columella þ þ þ
Thin vermillion upper lip þ þ þ
Atopic dermatitis þ þ þ
Hypermetropia þ þ þ
Oligodontia þ  þ
Camptodactyly  þ þ
Other features Cryptorchidism,
hip dysplasia,
multiple food
allergies, obesity
Diaphragmatic hernia,
kyphoscoliosis,
recurrent airway
infections, obesity
Chronic otitis, hearing loss,
obstructive sleep apnea,
recurrent airway infections,
asymmetry legs
Age at walking (months) 15 14 17
Language delay þ þ þ
Intellectual disability, IQ 53 54 Estimated 40–50
Hyperactive þ þ þ
Self mutilation þ  þ
Reduced sensitivity to pain þ þ þ
IUGR, intrauterine growth retardation; m, months; nr, not recorded; SD, standard deviation.
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that mutations in its family member KATNAL2 are a cause of non-
syndromic ID/autistic spectrumdisorders [Neale et al., 2012; Sand-
ers et al., 2012].
In conclusion, we report an example of reverse phenotyping by
describing three patients carrying nearly identical heterozygous
deletions of 13q12.3 and sharing a similar and recognizable phe-
notype. The critical region encompasses only three genes. For twoof
them, the microtubule-severing enzyme KATNAL1 and the chro-
matin-associated protein HMGB1, current knowledge qualifies
them as candidate genes for autosomal dominant ID. The future
identification of patients carrying point mutations would confirm
this hypothesis and help increase our knowledge of the complex
molecular pathways causing ID.
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